Dunaieva, I. “Liraglutide As a Means of Modifying Cardiometabolic Risk in Patients With Arterial Hypertension and Concomitant Obesity”. Inter Collegas, Vol. 12, no. 2, Apr. 2025, doi:10.35339/ic.2025.12.2.dun.